SUBSCRIBE

CATEGORIES

After Falling 13% in the Last Month, Should You Scoop Up Shares of Bristol Myers Squibb?

imageStock Markets21 minutes ago (Sep 23, 2021 12:31PM ET)

(C) Reuters. After Falling 13% in the Last Month, Should You Scoop Up Shares of Bristol Myers Squibb?

Biopharmaceuticals company Bristol Myers Squibb’s (NYSE:BMY) strong clinical and operational performance and continued momentum across its product portfolio helped it generate robust revenue growth in its last reported quarter. But given that its stock price has dipped recently, is now an opportune time to scoop up its shares? Read on.Global biopharmaceuticals company Bristol Myers Squibb (BMY) specializes in product development, licensing, and sale of biopharmaceutical products. Its product portfolio includes Opdivo for anti-cancer indications, Reblozyl for the treatment of anemia in adult patients with beta-thalassemia, and Revlimid, an oral immunomodulatory drug. BMY is headquartered in New York City.

Closing yesterday’s session at $60.15, the stock is trading 13.8% below the 52-week high of $69.75.

Though the stock’s price has dipped 13.1% over the past month, its impressive growth potential, significant clinical and regulatory milestones, and strategic collaborations with biopharmaceutical companies, including Pfizer , Inc. (NYSE:PFE), Otsuka Pharmaceutical Co., Ltd., and Bolt Biotherapeutics, Inc., are expected to boost its performance in the coming months. Furthermore, BMY’s robust product portfolio should help it achieve sustained growth.

Continue reading on StockNews

After Falling 13% in the Last Month, Should You Scoop Up Shares of Bristol Myers Squibb?

Health insurer Cigna names new CEO of Evernorth unit

Health insurer Cigna names new CEO of Evernorth unit
By Reuters – Sep 23, 2021

(Reuters) -U.S. health insurer Cigna Corp (NYSE:CI) on Thursday named company veteran Eric Palmer as president and chief executive officer of its Evernorth health services unit…

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

image

Our Apps

DOWNLOAD APPApp store

Investing.com

(C) 2007-2021 Fusion Media Limited. All Rights Reserved

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.